跳转至内容
Merck
CN
  • Focal experimental injury leads to widespread gene expression and histologic changes in equine flexor tendons.

Focal experimental injury leads to widespread gene expression and histologic changes in equine flexor tendons.

PloS one (2015-04-04)
Else Jacobson, Else Jacobsen, Andrew J Dart, Takamitsu Mondori, Neil Horadogoda, Leo B Jeffcott, Christopher B Little, Margaret M Smith
摘要

It is not known how extensively a localised flexor tendon injury affects the entire tendon. This study examined the extent of and relationship between histopathologic and gene expression changes in equine superficial digital flexor tendon after a surgical injury. One forelimb tendon was hemi-transected in six horses, and in three other horses, one tendon underwent a sham operation. After euthanasia at six weeks, transected and control (sham and non-operated contralateral) tendons were regionally sampled (medial and lateral halves each divided into six 3 cm regions) for histologic (scoring and immunohistochemistry) and gene expression (real time PCR) analysis of extracellular matrix changes. The histopathology score was significantly higher in transected tendons compared to control tendons in all regions except for the most distal (P ≤ 0.03) with no differences between overstressed (medial) and stress-deprived (lateral) tendon halves. Proteoglycan scores were increased by transection in all but the most proximal region (P < 0.02), with increased immunostaining for aggrecan, biglycan and versican. After correcting for location within the tendon, gene expression for aggrecan, versican, biglycan, lumican, collagen types I, II and III, MMP14 and TIMP1 was increased in transected tendons compared with control tendons (P < 0.02) and decreased for ADAMTS4, MMP3 and TIMP3 (P < 0.001). Aggrecan, biglycan, fibromodulin, and collagen types I and III expression positively correlated with all histopathology scores (P < 0.001), whereas lumican, ADAMTS4 and MMP14 expression positively correlated only with collagen fiber malalignment (P < 0.001). In summary, histologic and associated gene expression changes were significant and widespread six weeks after injury to the equine SDFT, suggesting rapid and active development of tendinopathy throughout the entire length of the tendon. These extensive changes distant to the focal injury may contribute to poor functional outcomes and re-injury in clinical cases. Our data suggest that successful treatments of focal injuries will need to address pathology in the entire tendon, and that better methods to monitor the development and resolution of tendinopathy are required.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
氯仿, contains 100-200 ppm amylenes as stabilizer, ≥99.5%
Sigma-Aldrich
氯仿, contains ethanol as stabilizer, ACS reagent, ≥99.8%
Sigma-Aldrich
透明质酸酶 来源于牛睾丸, Type I-S, lyophilized powder, 400-1000 units/mg solid
Sigma-Aldrich
软骨素酶 ABC 来源于普通变形杆菌, BSA free, lyophilized powder, specific activity 50-250 units/mg protein
Sigma-Aldrich
氯仿, contains amylenes as stabilizer, ACS reagent, ≥99.8%
Sigma-Aldrich
氯仿, ACS spectrophotometric grade, ≥99.8%, contains 0.5-1.0% ethanol as stabilizer
Sigma-Aldrich
氯仿, anhydrous, ≥99%, contains 0.5-1.0% ethanol as stabilizer
Sigma-Aldrich
氯仿, anhydrous, contains amylenes as stabilizer, ≥99%
Supelco
氯仿, analytical standard
Supelco
氯仿, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
保泰松
Sigma-Aldrich
氯仿, ≥99%, PCR Reagent, contains amylenes as stabilizer
Sigma-Aldrich
三氯乙酸钠, 97%
Supelco
残留溶剂-氯仿, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
抗多能聚糖抗体,人多能聚糖的a.a.1360-1439, Chemicon®, from rabbit
Sigma-Aldrich
β-D-阿洛糖, rare aldohexose sugar
Sigma-Aldrich
抗多能聚糖抗体,人多能聚糖的a.a.535-598, Chemicon®, from rabbit
Supelco
保泰松, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
GBF1抑制剂Golgicide A, ≥98% (HPLC)
保泰松, European Pharmacopoeia (EP) Reference Standard